
|Videos|July 27, 2021
How genomic testing can address accuracy issues with PSA screening and monitoring
Author(s)Urology Times staff
Brian T. Helfand, MD, PhD, discusses how the precision of genomic testing data can alleviate the accuracy issues associated with PSA testing for screening and monitoring prostate cancer.
Advertisement
Brian T. Helfand, MD, PhD, NorthShore University HealthSystem, discusses how the precision of genomic testing data can alleviate the accuracy issues associated with PSA testing for screening and monitoring prostate cancer.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants fast track designation to Enolen for localized prostate cancer
2
Pivotal trial of Butterfly Device for BPH reaches final completion
3
Trial to assess testosterone undecanoate in older men with hypogonadism
4
Genomic classifier score linked with focal therapy outcomes in prostate cancer
5




















